<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34915974</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>50</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title><ISOAbbreviation>Euro Surveill</ISOAbbreviation></Journal><ArticleTitle>An imported case of vaccine-derived poliovirus type 2, Spain in the context of the ongoing polio Public Health Emergency of International Concern, September 2021.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2101068</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2807/1560-7917.ES.2021.26.50.2101068</ELocationID><Abstract><AbstractText>The monthly retrospective search for unreported acute flaccid paralysis (AFP) cases conducted as a complementary component of the Spanish AFP surveillance system identified a case of AFP in a child admitted in Spain from Senegal during August 2021. Vaccine-derived poliovirus 2 was identified in the stool in September 2021. We present public health implications and response undertaken within the framework of the National Action Plan for Polio Eradication and the Public Health Emergency of International Concern.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chirlaque López</LastName><ForeName>María Dolores</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IMIB-Arrixaca, Murcia University, Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrerizo</LastName><ForeName>María</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Polio Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guzmán Herrador</LastName><ForeName>Bernardo R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masa-Calles</LastName><ForeName>Josefa</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Centre of Epidemiology, Carlos III Health Institute, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alarcón-Linares</LastName><ForeName>María Ester</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allende</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Group on Microbiology and Quality of Fruit and Vegetables, Food Science and Technology Department, CEBAS-CSIC, Espinardo, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aznar Cano</LastName><ForeName>Esteban</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barranco Boada</LastName><ForeName>María Isabel</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantero Gudino</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Immunization Programme Area, Directorate General of Public Health, Ministry of Health, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernández-Balbuena</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernández Dueñas</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Immunization Programme Area, Directorate General of Public Health, Ministry of Health, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernández-García</LastName><ForeName>María Dolores</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>National Polio Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García Hernández</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Epidemiology and Prevention Service, Public Health General Direction, Canary Islands Health Service, Santa Cruz de Tenerife, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García Ortúzar</LastName><ForeName>Visitación</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Lorca Public Health Service, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>López-Perea</LastName><ForeName>Noemí</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Centre of Epidemiology, Carlos III Health Institute, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez-Salcedo</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuropediatric Unit, Department of Paediatrics, University Hospital Virgen of Arrixaca, Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IMIB-Arrixaca, Murcia University, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Docón</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Microbiology Service. Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IMIB-Arrixaca, Murcia University, Murcia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ordobás Gavín</LastName><ForeName>María</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sub-Directorate General of Epidemiology, Community of Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodero Garduño</LastName><ForeName>Inmaculada</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sub-Directorate General of Epidemiology, Community of Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sierra Moros</LastName><ForeName>Maria José</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>CIBER in Infectious Diseases (CIBERINFEC), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simón Soria</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limia Sánchez</LastName><ForeName>Aurora</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Immunization Programme Area, Directorate General of Public Health, Ministry of Health, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suárez Rodríguez</LastName><ForeName>Berta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Coordinating Centre for Health Alerts and Emergencies (CCAES), Directorate General of Public Health, Ministry of Health, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Euro Surveill</MedlineTA><NlmUniqueID>100887452</NlmUniqueID><ISSNLinking>1025-496X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute Flaccid Paralysis</Keyword><Keyword MajorTopicYN="N">Poliovirus</Keyword><Keyword MajorTopicYN="N">eradication</Keyword><Keyword MajorTopicYN="N">public health emergency of international concern</Keyword><Keyword MajorTopicYN="N">vaccine-derived poliovirus</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>17</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34915974</ArticleId><ArticleId IdType="pmc">PMC8728495</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.50.2101068</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ministry of Health, Social Services and Equality. Plan de acción en España para la erradicación de la poliomielitis. [Action plan in Spain for Polio eradication]. Madrid: Ministry of Health, Social Services and Equality; 2016. Spanish. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/PlanPolio/docs/Plan_erradicacion_poliomielitis.pdf</Citation></Reference><Reference><Citation>World Health Organization (WHO). Statement of the thirtieth Polio IHR Emergency Committee. Geneva: WHO; 23 Nov 2021. Available from: https://www.who.int/news/item/23-11-2021-statement-of-the-thirtieth-polio-ihr-emergency-committee</Citation></Reference><Reference><Citation>Masa-Calles J, Torner N, López-Perea N, Torres de Mier MV, Fernández-Martínez B, Cabrerizo M, et al. Acute flaccid paralysis (AFP) surveillance: challenges and opportunities from 18 years’ experience, Spain, 1998 to 2015. Euro Surveill. 2018;23(47):1700423. 10.2807/1560-7917.ES.2018.23.47.1700423</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.47.1700423</ArticleId><ArticleId IdType="pmc">PMC6341937</ArticleId><ArticleId IdType="pubmed">30482263</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO). Polio Laboratory Manual, 4th edition. Geneva: WHO; 2004. Available from: http://apps.who.int/iris/bitstream/10665/68762/1/WHO_IVB_04.10.pdf</Citation></Reference><Reference><Citation>World Health Organization (WHO). An alternative test algorithm for poliovirus isolation and characterization. Polio Laboratory Manual 4th edition. Geneva: WHO; 2004: Available from: http://polioeradication.org/wp-content/uploads/2017/05/NewAlgorithmForPoliovirusIsolationSupplement1.pdf</Citation></Reference><Reference><Citation>Gerloff N, Sun H, Mandelbaum M, Maher C, Nix WA, Zaidi S, et al. Diagnostic assay development for Poliovirus eradication. J Clin Microbiol. 2018;56(2):e01624-17. 10.1128/JCM.01624-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01624-17</ArticleId><ArticleId IdType="pmc">PMC5786708</ArticleId><ArticleId IdType="pubmed">29212703</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative (GPEI). Classification and reporting of vaccine-derived polioviruses (VDPV). GPEI guidelines. Geneva: GPEI; 2016. Available from: https://polioeradication.org/wp-content/uploads/2016/09/Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf</Citation></Reference><Reference><Citation>Robert Koch Institut (RKI). WHO Reference Laboratories. Regional Reference Laboratory of the WHO/Europe for Poliomyelitis. Berlin: RKI; 2021. [Accessed: 13 Dec 2021]. Available from: https://www.rki.de/EN/Content/Institute/International/reference_labs/ref_lab_node.html</Citation></Reference><Reference><Citation>World Health Organization (WHO). Statement of the twenty-eighth polio IHR emergency committee. Geneva: WHO; 21 May 2021. Available from: https://www.who.int/news/item/21-05-2021-statement-following-the-twenty-eighth-ihr-emergency-committee-for-polio</Citation></Reference><Reference><Citation>World Health Organization (WHO). Standard operating procedures; Responding to a poliovirus event or outbreak version 3. Geneva: WHO; Jan 2019. Available from: https://polioeradication.org/wp-content/uploads/2016/07/sop-polio-outbreak-response-version-20193101.pdf</Citation></Reference><Reference><Citation>European Centre for Disease Prevention and Control (ECDC). Early Warning and Response System of the European Union (EWRS). Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/en/publications-data/early-warning-and-response-system-european-union-ewrs</Citation></Reference><Reference><Citation>Limia Sánchez A, Olmedo Lucerón C, et al. 2nd seroprevalence study in Spain, 2017-2018. Rev Esp Salud Pública. 2021;95:e202103059. Spanish. Available from: https://www.mscbs.gob.es/biblioPublic/publicaciones/recursos_propios/resp/revista_cdrom/VOL95/C_ESPECIALES/RS95C_202103059.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">33734212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health, Social Services and Equality. 2 Estudio de Seroprevalencia en España. [2nd seroprevalence study in Spain]. Madrid: Ministry of Health, Social Services and Equality; 2020. Spanish. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/comoTrabajamos/docs/EstudioSeroprevalencia_EnfermedadesInmunoprevenibles.pdf</Citation></Reference><Reference><Citation>Ministry of Health, Social Services and Equality. Coberturas de vacunación. Datos estadísticos. [Vaccine coverage. Statistical data]. Madrid: Ministry of Health, Social Services and Equality. [Accessed: 20 Nov 2021]. Spanish. Available from: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/calendario-y-coberturas/coberturas/home.htm</Citation></Reference><Reference><Citation>World Health Organization Regional Office for Europe (WHO/Europe). Certification of the Region’s polio-free status in 2002. Copenhagen: WHO/Europe. [Accessed: 20 Nov 2021]. Available from: https://www.euro.who.int/en/health-topics/communicable-diseases/poliomyelitis/activities/certification-and-maintenance-of-polio-free-status-in-the-european-region/european-regional-commission-for-the-certification-of-poliomyelitis-eradication/certification-of-the-regions-polio-free-status-in-2002</Citation></Reference><Reference><Citation>World Health Organization Regional Office for Europe (WHO/Europe). Report of the 33rd Meeting of the European Regional Certification Commission for Poliomyelitis Eradication. Copenhagen: WHO/Europe. 2019. Available from: https://www.euro.who.int/__data/assets/pdf_file/0016/414025/33rd-RCC-eng.pdf</Citation></Reference><Reference><Citation>National Centre of Epidemiology and National Centre for Microbiology Instituto de Salud Carlos III (ISCIII). Plan de acción en España para la Erradicación de la Poliomielitis. Vigilancia de la Parálisis Flácida Aguda y Vigilancia de Enterovirus en España, Informe año 2020. [Action Plan in Spain for polio eradication. Surveillance of acute flaccid paralysis and surveillance of enterovirus in Spain. 2020 report]. Madrid: ISCIII. 5 Nov 2021. Spanish. Available from: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/archivos%20A-Z/POLIO/Resultados_Vigilancia_Polio/Informes_Anuales_Polio/Informe_PFA_EV_2020_web.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>